Allergan Plc * Allergan acquires Chase Pharmaceuticals to expand CNS research and development pipeline and build on commitment to Alzheimer’s disease * Deal for an upfront payment of $125 million * Allergan to...
Novartis buys U.S. blood disease drugmaker in $665 million deal
Novartis (NOVN.S) is buying U.S.-based Selexys Pharmaceuticals in a deal worth up to $665 million, the Swiss drugmaker said on Monday, expanding its pipeline of medicines to combat blood diseases. Novartis, which last...
Competition Commission clears LG Life Sciences-LG Chem merger
NEW DELHI: Fair trade regulator CCI has approved the proposed merger of South Korea-based LG Life Sciences into LG Chem. Both companies, part of South Korean major LG, have a presence in India. The merger was announced...
Valeant agrees to sell Paragon to settle U.S. antitrust charges
Valeant Pharmaceuticals, which owns eye care products maker Bausch & Lomb, has agreed to sell Paragon Holdings to settle allegations that its acquisition of the smaller company was illegal under antitrust law, the...
Aurobindo Pharma may buy Portugal’s Generis, deal likely to be valued at $200 million
MUMBAI: Hyderabad-based Aurobindo PharmaBSE -0.63 % has expressed preliminary interest in acquiring Portuguese drug maker Generis Farmaceutica for about $200 million. Generis has a presence across anti-infective...
Valeant in talks to sell Salix stomach-drug unit in $10 billion deal
Canada’s Valeant Pharmaceuticals International Inc (VRX.TO) said on Tuesday it is in talks with third parties to sell its Salix stomach-drug business and other assets. The drugmaker did not name the potential...
Khandelwal Labs in talks to sell oncology portfolio to Italy’s Menarini
Drug maker Khandelwal Laboratories is in advanced talks to sell its oncology portfolio to Italy’s Menarini for close to Rs170 crore, two people familiar with the development said. “The acquisition will be carried out by...
Sun Pharma to buy Ocular Technologies from Auven Therapeutics
MUMBAI: India’s largest drug maker Sun PharmaBSE 0.56 % announced it agreed to acquire Ocular Technologies from Auven Therapeutics, a private equity firm focused on accelerated development of breakthrough drugs...
Sun Pharma buys eye care specialist Ocular Tech for $40 million
Mumbai:The country’s largest pharma company Sun Pharma on Wednesday acquired 100% equity in the US-based eye care specialist Ocular Technologies Sarl, owned by the private equity firm Auven Therapeutics, for a front...
Dr Reddy’s joins hands with Gland Pharma to market 8 ANDAs in US
HYDERABAD: Dr. Reddy’s LaboratoriesBSE 1.62 % today said it has entered into a collaboration with Gland Pharma to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications...
Everstone Capital invests Rs 220 crore in Rubicon Research
NEW DELHI: Everstone Capital has invested Rs 220 crore in contract research and drug delivery company Rubicon Research, the latest investment by the mid-market private equity firm, as it steps up its deal-making pace...
Eurolife to buy Baxter India’s form-fill-seal infusion business
NEW DELHI: Specialty pharmaceuticals firm Eurolife Healthcare has entered into an agreement to acquire Baxter India’s form-fill-seal (FFS) infusion business for an undisclosed amount. The acquisition will allow...
